E

EXONATE LIMITED

20 employees

Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Biopharma

Health Diagnostics

Health Care

2013

$6.1M

from 13 investors over 13 rounds

E

EXONATE LIMITED raised $1.9M on January 3, 2019

Investors: o2h ventures

E

EXONATE LIMITED raised undisclosed on October 29, 2018

Investors: Stoic Venture Capital and Uniseed

E

EXONATE LIMITED raised $6.1M on February 6, 2017

Investors: Wellcome Trust

E

EXONATE LIMITED raised $1.9M on November 30, 2016

Investors: Martlet Capital, Uniseed, ACF Investors, Parkwalk Advisors and Cambridge Angels

E

EXONATE LIMITED raised $1.2M on October 5, 2015

Investors: ACF Investors

E

EXONATE LIMITED raised $638K on November 3, 2013

Investors: The University of Nottingham, IP Group plc and Fusion IP plc